Semi-Annual Statement Of Cash Flows

Cyfuse Biomedical K.K. - Filing #7372948

Concept 2023-01-01 to
2023-09-30
2022-01-01 to
2022-09-30
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-532,243,000 JPY
-270,904,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.